Press Release

CARGO Therapeutics Announces $281.3 Million IPO

November 14, 2023

San Francisco – November 14, 2023 – Cooley advised the underwriters on CARGO Therapeutics’ $281.3 million initial public offering. Partners Denny Won, Charlie Kim, Kristin VanderPas and Dave Peinsipp led the Cooley team advising the underwriters.

JP Morgan, Jefferies, TD Cowen and Truist Securities acted as joint book-running managers for the IPO. CARGO offered a total of 18,750,000 shares of common stock, priced at $15 per share. CARGO also granted a 30-day option to the underwriters to purchase up to 2,812,500 additional shares of common stock. The listing began trading on the Nasdaq Global Select Market on November 10, 2023, under the symbol CRGX, and the IPO closed on November 14.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has more than 1,300 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of nearly 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.